Do analysts recommend PNTG or TACO?

The Pennant Group presently has a consensus price target of $41.60, suggesting a potential upside of 6.12%. Given The Pennant Group's stronger consensus rating and higher probable upside, research analysts clearly believe The Pennant Group is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score The Pennant Group 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88 Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, PNTG or TACO?

The Pennant Group has higher revenue and earnings than Berto Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio The Pennant Group $947.71M 1.44 $29.58M $0.90 43.56 Berto Acquisition N/A N/A N/A N/A N/A

Does the media refer more to PNTG or TACO?

In the previous week, The Pennant Group and The Pennant Group both had 4 articles in the media. The Pennant Group's average media sentiment score of 1.82 beat Berto Acquisition's score of 0.64 indicating that The Pennant Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Berto Acquisition 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate TACO or AMN?

AMN Healthcare Services has a consensus target price of $36.00, indicating a potential upside of 8.02%. Given AMN Healthcare Services' stronger consensus rating and higher possible upside, analysts clearly believe AMN Healthcare Services is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AMN Healthcare Services 1 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.38

Which has preferable valuation and earnings, TACO or AMN?

Berto Acquisition has higher earnings, but lower revenue than AMN Healthcare Services. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A AMN Healthcare Services $2.73B 0.47 -$95.70M $2.68 12.44

Does the media favor TACO or AMN?

In the previous week, AMN Healthcare Services had 1 more articles in the media than Berto Acquisition. MarketBeat recorded 5 mentions for AMN Healthcare Services and 4 mentions for Berto Acquisition. AMN Healthcare Services' average media sentiment score of 0.92 beat Berto Acquisition's score of 0.64 indicating that AMN Healthcare Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Berto Acquisition 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AMN Healthcare Services 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate OPK or TACO?

OPKO Health currently has a consensus price target of $1.55, indicating a potential downside of 1.27%. Given OPKO Health's stronger consensus rating and higher probable upside, equities analysts clearly believe OPKO Health is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OPKO Health 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, OPK or TACO?

Berto Acquisition has lower revenue, but higher earnings than OPKO Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OPKO Health $606.90M 1.93 -$225.68M -$0.09 N/A Berto Acquisition N/A N/A N/A N/A N/A

Does the media prefer OPK or TACO?

In the previous week, OPKO Health had 4 more articles in the media than Berto Acquisition. MarketBeat recorded 8 mentions for OPKO Health and 4 mentions for Berto Acquisition. OPKO Health's average media sentiment score of 0.82 beat Berto Acquisition's score of 0.64 indicating that OPKO Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OPKO Health 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Berto Acquisition 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend TACO or LMRI?

Lumexa Imaging has a consensus target price of $17.33, suggesting a potential upside of 50.86%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, analysts plainly believe Lumexa Imaging is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Lumexa Imaging 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67

Which has higher earnings & valuation, TACO or LMRI?

Berto Acquisition has higher earnings, but lower revenue than Lumexa Imaging. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A Lumexa Imaging $267.73M 4.12 -$47.10M -$0.49 N/A

Is TACO or LMRI more profitable?

Company Net Margins Return on Equity Return on Assets Berto Acquisition N/A N/A N/A Lumexa Imaging N/A N/A N/A

Does the media favor TACO or LMRI?

In the previous week, Berto Acquisition and Berto Acquisition both had 4 articles in the media. Lumexa Imaging's average media sentiment score of 0.72 beat Berto Acquisition's score of 0.64 indicating that Lumexa Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Berto Acquisition 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lumexa Imaging 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend CSTL or TACO?

Castle Biosciences currently has a consensus target price of $42.00, suggesting a potential upside of 29.91%. Given Castle Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Castle Biosciences is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Castle Biosciences 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.80 Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, CSTL or TACO?

Berto Acquisition has lower revenue, but higher earnings than Castle Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Castle Biosciences $344.23M 2.87 -$24.16M -$0.66 N/A Berto Acquisition N/A N/A N/A N/A N/A

Does the media favor CSTL or TACO?

In the previous week, Castle Biosciences had 1 more articles in the media than Berto Acquisition. MarketBeat recorded 5 mentions for Castle Biosciences and 4 mentions for Berto Acquisition. Castle Biosciences' average media sentiment score of 0.92 beat Berto Acquisition's score of 0.64 indicating that Castle Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Castle Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Berto Acquisition 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Berto Acquisition (TACO) Competitors

$10.48 0.00 (0.00%)

Closing price 09/11/2026 03:59 PM Eastern

Extended Trading

$10.49 +0.01 (+0.10%)

As of 09/11/2026 04:10 PM Eastern

Compare

TACO vs. PNTG, AMN, OPK, LMRI, and CSTL

Should you buy Berto Acquisition stock or one of its competitors? Berto Acquisition's main competitors and comparable companies include The Pennant Group (PNTG), AMN Healthcare Services (AMN), OPKO Health (OPK), Lumexa Imaging (LMRI), and Castle Biosciences (CSTL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Berto Acquisition compare to The Pennant Group?

The Pennant Group (NASDAQ:PNTG) and Berto Acquisition (NASDAQ:TACO) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment.

The Pennant Group has higher revenue and earnings than Berto Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Pennant Group	$947.71M	1.44	$29.58M	$0.90	43.56
Berto Acquisition	N/A	N/A	N/A	N/A	N/A

The Pennant Group has a net margin of 2.93% compared to Berto Acquisition's net margin of 0.00%. The Pennant Group's return on equity of 10.33% beat Berto Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Pennant Group	2.93%	10.33%	4.20%
Berto Acquisition	N/A	N/A	N/A

85.9% of The Pennant Group shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by company insiders. Comparatively, 13.2% of Berto Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, The Pennant Group and The Pennant Group both had 4 articles in the media. The Pennant Group's average media sentiment score of 1.82 beat Berto Acquisition's score of 0.64 indicating that The Pennant Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The Pennant Group	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Berto Acquisition	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

The Pennant Group has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Berto Acquisition has a beta of 0.08, indicating that its stock price is 92% less volatile than the broader market.

The Pennant Group presently has a consensus price target of $41.60, suggesting a potential upside of 6.12%. Given The Pennant Group's stronger consensus rating and higher probable upside, research analysts clearly believe The Pennant Group is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

The Pennant Group beats Berto Acquisition on 10 of the 11 factors compared between the two stocks.

How does Berto Acquisition compare to AMN Healthcare Services?

Berto Acquisition (NASDAQ:TACO) and AMN Healthcare Services (NYSE:AMN) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.

In the previous week, AMN Healthcare Services had 1 more articles in the media than Berto Acquisition. MarketBeat recorded 5 mentions for AMN Healthcare Services and 4 mentions for Berto Acquisition. AMN Healthcare Services' average media sentiment score of 0.92 beat Berto Acquisition's score of 0.64 indicating that AMN Healthcare Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Berto Acquisition	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AMN Healthcare Services	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Berto Acquisition has a beta of 0.08, suggesting that its share price is 92% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.38, suggesting that its share price is 62% less volatile than the broader market.

Berto Acquisition has higher earnings, but lower revenue than AMN Healthcare Services.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
AMN Healthcare Services	$2.73B	0.47	-$95.70M	$2.68	12.44

AMN Healthcare Services has a net margin of 3.06% compared to Berto Acquisition's net margin of 0.00%. AMN Healthcare Services' return on equity of 19.92% beat Berto Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
AMN Healthcare Services	3.06%	19.92%	5.93%

AMN Healthcare Services has a consensus target price of $36.00, indicating a potential upside of 8.02%. Given AMN Healthcare Services' stronger consensus rating and higher possible upside, analysts clearly believe AMN Healthcare Services is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AMN Healthcare Services	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38

99.2% of AMN Healthcare Services shares are owned by institutional investors. 13.2% of Berto Acquisition shares are owned by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

AMN Healthcare Services beats Berto Acquisition on 11 of the 12 factors compared between the two stocks.

How does Berto Acquisition compare to OPKO Health?

OPKO Health (NASDAQ:OPK) and Berto Acquisition (NASDAQ:TACO) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

64.6% of OPKO Health shares are owned by institutional investors. 44.7% of OPKO Health shares are owned by company insiders. Comparatively, 13.2% of Berto Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

OPKO Health currently has a consensus price target of $1.55, indicating a potential downside of 1.27%. Given OPKO Health's stronger consensus rating and higher probable upside, equities analysts clearly believe OPKO Health is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OPKO Health	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Berto Acquisition has a net margin of 0.00% compared to OPKO Health's net margin of -12.40%. Berto Acquisition's return on equity of 0.00% beat OPKO Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OPKO Health	-12.40%	-5.88%	-3.83%
Berto Acquisition	N/A	N/A	N/A

OPKO Health has a beta of 1.5, meaning that its share price is 50% more volatile than the broader market. Comparatively, Berto Acquisition has a beta of 0.08, meaning that its share price is 92% less volatile than the broader market.

In the previous week, OPKO Health had 4 more articles in the media than Berto Acquisition. MarketBeat recorded 8 mentions for OPKO Health and 4 mentions for Berto Acquisition. OPKO Health's average media sentiment score of 0.82 beat Berto Acquisition's score of 0.64 indicating that OPKO Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OPKO Health	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Berto Acquisition	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Berto Acquisition has lower revenue, but higher earnings than OPKO Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OPKO Health	$606.90M	1.93	-$225.68M	-$0.09	N/A
Berto Acquisition	N/A	N/A	N/A	N/A	N/A

Summary

OPKO Health beats Berto Acquisition on 9 of the 12 factors compared between the two stocks.

How does Berto Acquisition compare to Lumexa Imaging?

Berto Acquisition (NASDAQ:TACO) and Lumexa Imaging (NASDAQ:LMRI) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

Berto Acquisition has higher earnings, but lower revenue than Lumexa Imaging.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
Lumexa Imaging	$267.73M	4.12	-$47.10M	-$0.49	N/A

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
Lumexa Imaging	N/A	N/A	N/A

Lumexa Imaging has a consensus target price of $17.33, suggesting a potential upside of 50.86%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, analysts plainly believe Lumexa Imaging is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, Berto Acquisition and Berto Acquisition both had 4 articles in the media. Lumexa Imaging's average media sentiment score of 0.72 beat Berto Acquisition's score of 0.64 indicating that Lumexa Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Berto Acquisition	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lumexa Imaging	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Lumexa Imaging beats Berto Acquisition on 6 of the 6 factors compared between the two stocks.

How does Berto Acquisition compare to Castle Biosciences?

Castle Biosciences (NASDAQ:CSTL) and Berto Acquisition (NASDAQ:TACO) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

Castle Biosciences has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market. Comparatively, Berto Acquisition has a beta of 0.08, meaning that its stock price is 92% less volatile than the broader market.

92.6% of Castle Biosciences shares are held by institutional investors. 6.1% of Castle Biosciences shares are held by company insiders. Comparatively, 13.2% of Berto Acquisition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Castle Biosciences had 1 more articles in the media than Berto Acquisition. MarketBeat recorded 5 mentions for Castle Biosciences and 4 mentions for Berto Acquisition. Castle Biosciences' average media sentiment score of 0.92 beat Berto Acquisition's score of 0.64 indicating that Castle Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Castle Biosciences	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Berto Acquisition	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Castle Biosciences currently has a consensus target price of $42.00, suggesting a potential upside of 29.91%. Given Castle Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Castle Biosciences is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Castle Biosciences	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Berto Acquisition has a net margin of 0.00% compared to Castle Biosciences' net margin of -5.43%. Berto Acquisition's return on equity of 0.00% beat Castle Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Castle Biosciences	-5.43%	-4.15%	-3.45%
Berto Acquisition	N/A	N/A	N/A

Berto Acquisition has lower revenue, but higher earnings than Castle Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Castle Biosciences	$344.23M	2.87	-$24.16M	-$0.66	N/A
Berto Acquisition	N/A	N/A	N/A	N/A	N/A

Summary

Castle Biosciences beats Berto Acquisition on 9 of the 13 factors compared between the two stocks.

Get Berto Acquisition News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TACO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TACO vs. The Competition

Export

Metric	Berto Acquisition	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$342.07M	$9.84B	$7.16B	$12.85B
Dividend Yield	N/A	2.61%	2.57%	11.72%
P/E Ratio	N/A	33.53	274.94	25.36
Price / Sales	N/A	4.89	685.43	116.41
Price / Cash	N/A	125.15	76.65	51.52
Price / Book	N/A	5.29	10.33	6.20
Net Income	N/A	$313.25M	$3.50B	$358.50M
7 Day Performance	-0.14%	-1.26%	-3.32%	-2.35%
1 Month Performance	0.24%	-1.53%	-0.53%	-3.23%
1 Year Performance	2.44%	58.44%	23.51%	8.79%

Berto Acquisition Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TACO Berto Acquisition	0.6552 of 5 stars	$10.48 flat	N/A	+2.7%	$342.07M	N/A	N/A	7,892	News Coverage Short Interest Increase
PNTG The Pennant Group	3.8745 of 5 stars	$37.86 +0.3%	$41.60 +9.9%	+53.2%	$1.32B	$947.71M	42.07	9,700	Positive News
AMN AMN Healthcare Services	1.9264 of 5 stars	$33.27 -0.8%	$31.43 -5.5%	+82.9%	$1.30B	$3.43B	12.41	2,664	Analyst Forecast
OPK OPKO Health	0.6654 of 5 stars	$1.69 +11.2%	$1.55 -8.3%	+12.1%	$1.13B	$606.90M	N/A	1,373	High Trading Volume
LMRI Lumexa Imaging	3.1083 of 5 stars	$11.75 +0.9%	$17.33 +47.5%	N/A	$1.12B	$267.73M	N/A	5,019	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TACO) was last updated on 9/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Berto Acquisition (TACO) Competitors

TACO vs. PNTG, AMN, OPK, LMRI, and CSTL

How does Berto Acquisition compare to The Pennant Group?

Summary

How does Berto Acquisition compare to AMN Healthcare Services?

Summary

How does Berto Acquisition compare to OPKO Health?

Summary

How does Berto Acquisition compare to Lumexa Imaging?

Summary

How does Berto Acquisition compare to Castle Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TACO vs. The Competition

Berto Acquisition Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Berto Acquisition (TACO) Competitors

TACO vs. PNTG, AMN, OPK, LMRI, and CSTL

How does Berto Acquisition compare to The Pennant Group?

Which has stronger valuation and earnings, PNTG or TACO?

Is PNTG or TACO more profitable?

Do institutionals and insiders have more ownership in PNTG or TACO?

Does the media refer more to PNTG or TACO?

Which has more risk and volatility, PNTG or TACO?

Do analysts recommend PNTG or TACO?

Summary

How does Berto Acquisition compare to AMN Healthcare Services?

Does the media favor TACO or AMN?

Which has more risk & volatility, TACO or AMN?

Which has preferable valuation and earnings, TACO or AMN?

Is TACO or AMN more profitable?

Do analysts rate TACO or AMN?

Do insiders and institutionals believe in TACO or AMN?

Summary

How does Berto Acquisition compare to OPKO Health?

Do insiders & institutionals believe in OPK or TACO?

Do analysts rate OPK or TACO?

Is OPK or TACO more profitable?

Which has more volatility & risk, OPK or TACO?

Does the media prefer OPK or TACO?

Which has higher valuation & earnings, OPK or TACO?

Summary

How does Berto Acquisition compare to Lumexa Imaging?

Which has higher earnings & valuation, TACO or LMRI?

Is TACO or LMRI more profitable?

Do analysts recommend TACO or LMRI?

Does the media favor TACO or LMRI?

Summary

How does Berto Acquisition compare to Castle Biosciences?

Which has more risk & volatility, CSTL or TACO?

Do insiders & institutionals believe in CSTL or TACO?

Does the media favor CSTL or TACO?

Do analysts recommend CSTL or TACO?

Is CSTL or TACO more profitable?

Which has better earnings and valuation, CSTL or TACO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TACO vs. The Competition

Berto Acquisition Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools